Literature DB >> 19162569

Specific GC-MS/MS stable-isotope dilution methodology for free 9- and 10-nitro-oleic acid in human plasma challenges previous LC-MS/MS reports.

Dimitrios Tsikas1, Alexander Zoerner, Anja Mitschke, Yahya Homsi, Frank-Mathias Gutzki, Jens Jordan.   

Abstract

Nitrated unsaturated fatty acids including nitro-oleic acid (NO(2)-OA) have been measured in human blood samples in their free and esterified forms. Plasma concentrations in healthy subjects have been reported to be of the order of 600 nM for free NO(2)-OA and 300 nM for esterified NO(2)-OA, as measured by LC-MS/MS. In the present article we report a GC-MS/MS method for the specific and accurate quantification of two NO(2)-OA isomers, i.e., 9-NO(2)-OA and 10-NO(2)-OA, in human plasma using newly prepared, isolated, characterized and standardized (15)N-labeled analogs. This method involves SPE extraction of fatty acids from slightly acidified plasma samples (pH 5), conversion to their pentafluorobenzyl (PFB) esters, isolation by HPLC, solvent extraction from a single HPLC fraction and GC-MS/MS analysis in the electron capture negative-ion chemical ionization (ECNICI) mode. Quantification was performed by selected-reaction monitoring (SRM) of m/z 46 ([NO(2)](-)) and m/z 47 ([(15)NO(2)](-)) produced by collision-induced dissociation (CID) from the parent ions [M-PFB](-) at m/z 326 for endogenous 9-NO(2)-OA and 10-NO(2)-OA and m/z 327 for the internal standards 9-(15)NO(2)-OA and 10-(15)NO(2)-OA. We partially validated the GC-MS/MS method for 9-NO(2)-OA and 10-NO(2)-OA in human plasma and quantified these nitro-oleic species in plasma of 15 healthy volunteers. We identified two isomers, i.e., 9-NO(2)-OA and 10-NO(2)-OA, in human plasma under physiological conditions and found these nitrated fatty acids at a mean concentration of 1 nM each. This concentration is about 600 times lower than that reported by others using LC-MS/MS. Our GC-MS/MS studies on nitro-oleic acid and 3-nitrotyrosine suggest that the extent of nitration of biomolecules such as unsaturated fatty acids and tyrosine is very low in health. In this article we discuss analytical and biological ramifications potentially associated with measurement of nitrated biomolecules in biological systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162569     DOI: 10.1016/j.jchromb.2008.12.062

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  16 in total

1.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

2.  Gas-phase fragmentation analysis of nitro-fatty acids.

Authors:  Gustavo Bonacci; Eliana K Asciutto; Steven R Woodcock; Sonia R Salvatore; Bruce A Freeman; Francisco J Schopfer
Journal:  J Am Soc Mass Spectrom       Date:  2011-07-13       Impact factor: 3.109

3.  Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses.

Authors:  Gabriela Ambrozova; Hana Martiskova; Adolf Koudelka; Thorben Ravekes; Tanja K Rudolph; Anna Klinke; Volker Rudolph; Bruce A Freeman; Steven R Woodcock; Lukas Kubala; Michaela Pekarova
Journal:  Free Radic Biol Med       Date:  2015-11-24       Impact factor: 7.376

Review 4.  Signaling actions of electrophiles: anti-inflammatory therapeutic candidates.

Authors:  Alison L Groeger; Bruce A Freeman
Journal:  Mol Interv       Date:  2010-02

5.  Nitroalkene fatty acids mediate activation of Nrf2/ARE-dependent and PPARγ-dependent transcription by distinct signaling pathways and with significantly different potencies.

Authors:  Darcy J P Bates; Pamela K Smitherman; Alan J Townsend; S Bruce King; Charles S Morrow
Journal:  Biochemistry       Date:  2011-08-17       Impact factor: 3.162

6.  Nitro-oleic acid and epoxyoleic acid are not altered in obesity and type 2 diabetes: reply.

Authors:  Francisco J Schopfer; Bruce A Freeman; Nicholas K H Khoo
Journal:  Cardiovasc Res       Date:  2014-02-21       Impact factor: 10.787

7.  Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine.

Authors:  Sonia R Salvatore; Dario A Vitturi; Paul R S Baker; Gustavo Bonacci; Jeffrey R Koenitzer; Steven R Woodcock; Bruce A Freeman; Francisco J Schopfer
Journal:  J Lipid Res       Date:  2013-04-25       Impact factor: 5.922

8.  Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts.

Authors:  Luis Villacorta; Lin Chang; Sonia R Salvatore; Tomonaga Ichikawa; Jifeng Zhang; Danica Petrovic-Djergovic; Lingyun Jia; Harald Carlsen; Francisco J Schopfer; Bruce A Freeman; Y Eugene Chen
Journal:  Cardiovasc Res       Date:  2013-01-17       Impact factor: 10.787

9.  Nitro-fatty acids occur in human plasma in the picomolar range: a targeted nitro-lipidomics GC-MS/MS study.

Authors:  Dimitrios Tsikas; Alexander A Zoerner; Anja Mitschke; Frank-Mathias Gutzki
Journal:  Lipids       Date:  2009-08-22       Impact factor: 1.880

10.  Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.

Authors:  Francisco J Schopfer; Marsha P Cole; Alison L Groeger; Chen-Shan Chen; Nicholas K H Khoo; Steven R Woodcock; Franca Golin-Bisello; U Nkiru Motanya; Yong Li; Jifeng Zhang; Minerva T Garcia-Barrio; Tanja K Rudolph; Volker Rudolph; Gustavo Bonacci; Paul R S Baker; H Eric Xu; Carlos I Batthyany; Y Eugene Chen; Tina M Hallis; Bruce A Freeman
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.